• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 3. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 4. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 5. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583

Comprehensive Overview of 4-(hydroxyamino)methylbenzonitrile (CAS No. 65266-78-6): Properties, Applications, and Research Insights

4-(hydroxyamino)methylbenzonitrile (CAS No. 65266-78-6) is an organic compound featuring a benzonitrile core substituted with a hydroxyamino methyl group at the para position. This structurally unique molecule has garnered attention in pharmaceutical and agrochemical research due to its potential as a versatile intermediate. The presence of both nitrile and hydroxyamino functional groups enables diverse chemical transformations, making it valuable for synthesizing bioactive molecules.

Recent studies highlight the role of 4-(hydroxyamino)methylbenzonitrile in developing enzyme inhibitors, particularly those targeting metalloproteinases and oxidoreductases. Researchers are exploring its utility in designing small-molecule therapeutics for inflammatory conditions, leveraging its ability to modulate reactive oxygen species (ROS) pathways. The compound’s electron-withdrawing nitrile group enhances its stability in biological systems, a property increasingly sought after in drug discovery pipelines.

In material science, derivatives of 65266-78-6 have shown promise as ligands for catalytic systems, particularly in asymmetric synthesis. Its chelating potential via the hydroxyamino group allows coordination with transition metals, enabling applications in green chemistry initiatives. This aligns with the growing demand for sustainable catalysts in industrial processes, a trending topic in ESG (Environmental, Social, and Governance)-driven research.

Analytical characterization of 4-(hydroxyamino)methylbenzonitrile typically involves HPLC-MS and NMR spectroscopy, with its polar nitrile moiety facilitating detection in reverse-phase chromatographic methods. The compound’s logP value (estimated at 0.8–1.2) suggests moderate hydrophilicity, a feature optimized in recent structure-activity relationship (SAR) studies for improved bioavailability.

From a regulatory perspective, CAS 65266-78-6 is not classified as hazardous under major chemical inventories, though standard laboratory precautions apply. Its low ecotoxicity profile makes it a candidate for biodegradable chemical design, addressing the surge in searches for eco-friendly intermediates. Patent literature reveals its use in photoresist formulations for semiconductor manufacturing, tapping into the microelectronics boom.

Ongoing investigations focus on the kinetic resolution of 4-(hydroxyamino)methylbenzonitrile enantiomers using biocatalysts, responding to the pharmaceutical industry’s need for chiral purity. Computational chemistry models predict its hydrogen-bonding capacity could enable novel supramolecular architectures, a hot topic in nanotechnology forums. These multidisciplinary applications position 65266-78-6 as a compound bridging traditional organic synthesis with cutting-edge technologies.

For synthetic chemists, the N-alkylation and reductive amination pathways of 4-(hydroxyamino)methylbenzonitrile offer routes to heterocyclic scaffolds prevalent in kinase inhibitors. Its compatibility with click chemistry protocols further expands utility in combinatorial libraries, meeting demands from high-throughput screening platforms. Recent publications correlate its molecular dipole moment (～3.5 D) with enhanced protein-binding specificity.

In conclusion, 4-(hydroxyamino)methylbenzonitrile exemplifies how functional group synergy drives innovation across sectors. As precision chemistry gains traction, this compound’s dual electrophilic/nucleophilic character ensures its relevance in addressing challenges from targeted drug delivery to molecular electronics—topics dominating contemporary scientific discourse.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)